These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 175564)

  • 1. [Type II primary hyperlipoproteinemia: effect of dietary treatment and cholestyramine on serum lipids and lipoproteins].
    Vaverková H; Kubasta M; Zmeskal A; Procházka J; Vrublowský P; Podivínský
    Vnitr Lek; 1976 Jan; 22(1):73-83. PubMed ID: 175564
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.
    Glueck CJ; Fallat R; Tsang R
    Pediatrics; 1973 Nov; 52(5):669-79. PubMed ID: 4355362
    [No Abstract]   [Full Text] [Related]  

  • 3. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of hypolipidemic drugs on serum lipoproteins.
    Carlson LA; Olsson AG
    Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of hyperlipidemic states.
    Havel RJ; Kane JP
    Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic failure in familial type II hyperlipoproteinemia.
    Witters LA; Herbert PN; Shulman RS; Krauss RM; Levy RI
    Metabolism; 1976 Sep; 25(9):1017-26. PubMed ID: 183084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

  • 10. [Letter: Hyperlipoproteinemia].
    Schlierf G
    Dtsch Med Wochenschr; 1974 Feb; 99(8):373-4. PubMed ID: 4822448
    [No Abstract]   [Full Text] [Related]  

  • 11. Lecithin: cholestrol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type IIa hyperlipoproteinaemia.
    Wallentin L
    Eur J Clin Invest; 1978 Dec; 8(6):383-9. PubMed ID: 217692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperlipoproteinemia].
    Meinders AE
    Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
    [No Abstract]   [Full Text] [Related]  

  • 13. The pediatrician's role in genetic hyperlipidemias.
    Schleman MM
    Del Med J; 1981 Sep; 53(9):473-4. PubMed ID: 7338289
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial and acquired hyperlipoproteinemias in children and adolescents.
    Mellies M; Glueck CJ; Fallat RW; Tsang R
    Postgrad Med; 1974 Nov; 56(6):94-100. PubMed ID: 4372590
    [No Abstract]   [Full Text] [Related]  

  • 15. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Why such high serum levels of vitamin A?
    Garry PG
    Pediatrics; 1975 Jun; 55(6):899-900. PubMed ID: 1134897
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholestyramine and ileal by-pass in the treatment of familial hypercholesterolaemia.
    Miettinen TA; Lempinen M
    Eur J Clin Invest; 1977 Dec; 7(6):509-14. PubMed ID: 204491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholestyramine administration on serum lipids and on nitrogen balance in familial hypercholesterolemia.
    Howard RP; Brusco OJ; Furman RH
    J Lab Clin Med; 1966 Jul; 68(1):12-20. PubMed ID: 5945620
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypolipidemic drugs and lipoprotein metabolism.
    Levy RI; Langer T
    Adv Exp Med Biol; 1972; 26(0):155-63. PubMed ID: 4370081
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.